Affiliation:
1. Amity Institute of Virology and Immunology Amity University Sector-125 Amity University Noida 201313 Uttar Pradesh India
2. LMU Biocenter Martinsreid Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Geschwister-Scholl-Platz 1 München Germany
Abstract
AbstractMagnetic resonance imaging (MRI) is a non‐invasive molecular imaging tool being extensively employed in clinical and biomedical research for the detection of a broad spectrum of diseases. This technique offers remarkable spatial resolution, good tissue penetration and a high soft tissue contrast. Contrast agents (CAs) have been regularly used in MRI tests to enhance the resolution of MR images and to visualize the diseased sites in the body. In the past years, considerable efforts have been devoted towards developing new theranostic MRI agents that can be tailored to integrate the targeting and therapeutic functions in a single agent. In this review, we have underlined the role of the MRI CAs in the developing field of ‘theranostics’ and their recent applications in the combined imaging and therapy of different types of tumors. In addition, this review also outlines the different categories of MRI CAs and their comprehensive classification based on different criteria such as chemical composition, relaxation mechanism and biodistribution with clinically relevant examples.